Etomidate Versus Propofol in CABG Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

Also called NCT06068764

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose supportive care
Phase
Phase 4
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06068764
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06068764. Randomized; single masking; primary purpose supportive care. Start 2023-12-05 (actual); primary completion 2025-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Etomidate Versus Propofol in CABG Surgery
Acronym
ETOPRO
Intervention (Drug)
Etomidate
Intervention (Drug)
Propofol
Lead sponsor
Hartford Hospital (class: other)

Record details

Record id
cardio:ct-nct06068764
Content hash
e3eb981ff033cfa8d04d71a60581db85444160fb43ce7e0c9bb866c4b244be76